STRS OHIO - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 76 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2019. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.

Quarter-by-quarter ownership
STRS OHIO ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q2 2019$686,000
+4.4%
7,2000.0%0.00%0.0%
Q1 2019$657,000
+20.3%
7,2000.0%0.00%0.0%
Q4 2018$546,000
-5.2%
7,2000.0%0.00%0.0%
Q3 2018$576,000
-19.4%
7,2000.0%0.00%0.0%
Q2 2018$715,000
+22.6%
7,2000.0%0.00%0.0%
Q1 2018$583,000
+2.8%
7,2000.0%0.00%
+50.0%
Q4 2017$567,000
-14.6%
7,2000.0%0.00%
-33.3%
Q3 2017$664,0007,2000.00%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q2 2019
NameSharesValueWeighting ↓
Maso Capital Partners Ltd 164,500$15,011,00010.32%
HHLR ADVISORS, LTD. 2,751,200$251,047,0006.99%
Dalton Investments, Inc. 113,851$10,389,0004.54%
Point72 Hong Kong Ltd 115,939$10,579,0004.17%
York Capital Management Global Advisors, LLC 991,233$90,450,0004.05%
RUDMAN ERROL M 58,000$5,293,0003.57%
Greenwoods Asset Management Ltd 479,580$43,762,0002.69%
Parametrica Management Ltd 3,663$334,0000.71%
Temasek Holdings (Private) Ltd 990,000$90,338,0000.62%
Athos Capital Ltd 8,290$756,0000.49%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders